| Literature DB >> 32973991 |
Haiyan Wang1, Dongmei Tang1, Yongzhen Wu1, Li Zhou2, Shan Sun3.
Abstract
BACKGROUND: Sound therapy is a clinically common method of tinnitus management. Various forms of sound therapy have been developed, but there are controversies regarding the selection criteria and the efficacy of different forms of sound therapy in the clinic. Our goal was to review the types and forms of sound therapy and our understanding of how the different characteristics of tinnitus patients influence their curative effects so as to provide a reference for personalized choice of tinnitus sound therapy.Entities:
Keywords: acoustic stimulation; principle effect; sound therapy; tinnitus
Year: 2020 PMID: 32973991 PMCID: PMC7493236 DOI: 10.1177/2040622320956426
Source DB: PubMed Journal: Ther Adv Chronic Dis ISSN: 2040-6223 Impact factor: 5.091
Type of intervention, sample size, research duration, assessment methods, and main findings of articles reviewed.
| Intervention | Reference | Sample size | Study design | Research duration | Outcome measures | Main findings | |
|---|---|---|---|---|---|---|---|
| Intervention time | Follow-up time: | ||||||
| Masking | Hesser | 35 | RCT | 90 s × 4 | 90 s × 4 | Self-reported tinnitus interference and the Digit-Symbol subtest | Individuals receiving the instructions to control the background sounds (group 1) exhibited a significantly steeper increase of tinnitus interference over the trials than those receiving the no-control instructions (group 2); moreover, group 2 improved at a significantly faster rate on the measure of cognitive functioning over trials in comparison with group 1; finally, none of presence of tinnitus and ratings of satisfaction with the performance, background sound interfering with performance, and background sound had impact on outcome |
| Masking | Li | 28 | RCT | Treated for 30 min, three times a day, for a 3-month period | Pre-intervention (baseline), and 2, 4, 8 and 12 weeks post-intervention | THI, VAS | The mixed pure-tones group showed lower scores in THI, VAS loudness and annoyance than those at baseline after 3 months; the VAS loudness and annoyance scores of the mixed pure-tones group were lower than the BBN group at 8 and 12 weeks but there was no significant difference at 2 and 4 weeks |
| Masking | Henry | 148 | RCT | 6 months | 18 months | THI | The participants received TM, TRT, and TED had significantly decreased in THI relative to WLC group; the scores of THI in the three treatment groups got significantly decreased in the first 6 months, and relatively similar effectiveness by 6 months and beyond |
| TRT | Forti | 45 | Clinical Trial | 18 months | 36 months | THI, VAS | There were significant improvements during therapy and the mean THI was lowered by more than 20 points; these improvements persisted 18 months after treatment completion; furthermore, the percentage of patients reporting the disappearance of self-perceived disability induced by tinnitus increased continuously after treatment completion; there was only one patient whose condition worsened in the follow up |
| TRT | Korres | 63 | Controlled Clinical Trial | 12 months | 12 months | THI, VAS | On final evaluation the THI score was statistically significantly improved in the TRT group compared with control group (treated with vasoactive agents); additionally, mean VAS scores were statistically improved in the study group, in all measures (work, sleep, relaxation, concentration); none of these measures were significantly improved in the control group |
| TRT | Tyler | 48 | RCT | 12 months | 12 months | THQ | After 12 months, no significant differences in improvement rate were observed among groups |
| TRT | Bauer and Brozoski[ | 32 | Controlled clinical trial | 18 months | 18 months | THI, TEQ, TIQ, subjective tinnitus loudness rating, and tinnitus LM | Both TRT and counseling are effective in reducing the annoyance and impact of tinnitus; compared with counseling, TRT participants rated their tinnitus less loud at 12 and 18 months (evaluated with TEQ); furthermore, the TRT group showed a very significant decrease of TIQ over time, whereas the control group did not; there were no significant decreases in tinnitus loudness sensation levels within each group across the four assessment periods |
| TRT | Barozzi | 20 | Controlled clinical trial | 6 months | 6 months | THI, NRS | Significant improvements were obtained in both groups after fitting; no significant difference was found between the two groups using one or the other type of sound; two thirds of participants preferred to choose white noise as the treatment sound, while the rest indicated red noise as the preferred sound and no one chose pink noise |
| TRT | Reddy | 57 | Clinical trial | 3 months | 3 months | THI | After completion of therapy, tinnitus completely disappeared in 34 (59.65%) patients; improvement in tinnitus perception was observed in 49 (85.96%) patients; there was no improvement in tinnitus perception in 8 (14.03%) patients |
| HNMT | Argstatter | 290 | Comparative study | 5 days | 5 days | TQ | Both treatment groups achieved a statistically relevant reduction in TQ scores, though 66% of patients in the music therapy group attained a clinically meaningful improvement compared with 33% in the counseling group; it is found that initial tinnitus score and type of therapy with an OR for the music therapy compared with the counseling had an influence on therapy outcome |
| HNMT | Krick | 61 | Clinical trial | 1 week | 1 week | fMRI, TQ | Treatment of the TG with HNMT resulted in an augmented DMN activity in the PCC by 2.5% whereas no change was found in AC and PTC groups; this enhancement of PCC activity correlated with a reduction in tinnitus distress (measured by TQ) |
| HNMT | Krick and Argstatter[ | 63 | Clinical trial | 1 week | 3 weeks | TQ, MRI | The therapy significantly reduced the TQ score in the treatment group compared with the PTC group; in both treatment group and AC group, the 1-week therapy yielded GM increase in the precuneus |
| TMNMT | Okamoto | 23 | RCT | 12 months | 12 months | TQ, VAS, MEG (ASSR and N1m) | The TMNMT group showed significantly reduced subjective tinnitus loudness and concomitantly exhibited reduced evoked activity in auditory cortex areas corresponding to the tinnitus frequency compared with patients who had received an analogous placebo notched music treatment or monitoring; moreover, all reduction effects observed in the target group were statistically significant already after 6 months of treatment; after 12 months of treatment the results of ASSR showed a highly significant correlation between tinnitus loudness change and auditory-evoked response ratio change |
| TMNMT | Stein | 100 | RCT | Treated for 2 h a day for 3 consecutive months | 4 months | THQ, VAS, TQ, THQ, the subscales of the VAS | There were no significant effects for both primary outcome measures (pre |
| TMNMT | Teismann | 20 | RCT | 6 h/day, 5 subsequent days | 31 days | TQ, MEG (ASSR and N1m) | A significant improvement in subjective tinnitus loudness, tinnitus-related distress, and tinnitus-related auditory-cortex-evoked activity (ASSR and N1m) were observed in patients with tinnitus frequencies ⩽8 kHz; however, there was no improvement in patients with tinnitus frequencies >8 kHz; though tinnitus loudness and N1m were significantly reduced after TMNMT completion, the effects becoming less with time |
| TMNMT | Schad | 30 | RCT | Treated for 6 h a day for 2 weeks | 4 weeks | VNS, LM, TFI | All groups showed a pronounced decrease in mean TFI; however, only the improvement seen for the notched group is considered a clinically meaningful reduction based on criteria set for the TFI; the VNS and LM results showed the most improvement for the notched group immediately following treatment |
| TMNMT | Stein | 9 | Clinical trial | 3 h on 3 consecutive days | 3 days | VAS-L, MEG | TMNMT exposure reduced subjective tinnitus loudness and neural activity evoked by the tinnitus tone in the temporal, parietal, and frontal regions within the N1m time interval; the reduction of auditory cortex activity was related to the decrease of tinnitus loudness; in addition, the reduction of tinnitus-related neural activity persisted and accumulated over 3 days |
| PM | Theodoroff | 60 | RCT | 3 months | 3 months | TFI, NRS, and tinnitus LM | Treatment with PM or NS had a greater reduction in mean TFI compared with treatment with BSG, and treatment with PM results in greater reduction in mean NRS of tinnitus loudness compared with the other groups; the effects on the LM at 1 kHz are virtually indistinguishable between PM and NS group |
| PM | Vanneste | 26 | RCT | Treated for 3 h a day for 1 month | 1 month | HADS, VAS-L and VAS-A, EEG | Compared with baseline, the sham and compensation treatment groups revealed no significant outcomes for VAS-L, VAS-A, depression and anxiety as measured with the HADS or EEG; however, the overcompensation treatment group scored worse in VAS-L, VAS-A, and depression, and demonstrated for an increase of α2 activity within the left dorsal anterior cingulate cortex, as well as for β1 and β2 band in the left pregenual anterior cingulate cortex |
| PM | Mahboubi | 18 | RCT | Treated for 2 h a day for 3 months | 3 months | VAS-L, THI, BAI, MML, and RI | With customized sound therapy, all of mean loudness, the scores of THI and BAI, and MML decreased; the residual inhibition type and duration did not change significantly; however, the number of subjects with complete RI increased from 1 to 4; after 3 months of BBN therapy, only significant improvements in BAI and MML were seen; the changes in tinnitus loudness and THI with the customized sound therapy were statistically greater than those of BBN therapy |
| CR | Hauptmann | 189 | Clinical trial | 12 months | 12 months | TBF-12, CGI-I7 and NRS | The scores of TBF-12 and CGI-I7 had a significant decrease after 12 months of treatment; NRS loudness and annoyance improved; after 12 months of treatment, about half of patients reported that tinnitus has no negative influence on their life anymore |
| CR | Tass[ | 63 | RCT | 12 weeks | 10 months | VAS, TQ and EEG | TQ scores and VAS-L/VAS-A were significantly reduced compared with baseline in G1 to G4 with the strongest improvements in G1 and G3 (CR group); while in G2 (noisy CR group), the VAS-L/VAS-A only showed significant reductions in on-stimulation and the difference between on- and off-stimulation effect was strongest; G4 (reduced stimulation time of 1 h/day) showed a similar effect to G1 and G3 but was less effective; in contrast, G5 (the placebo group) showed no change in on- and off-stimulation; furthermore, the effects gained in 12 weeks of treatment showed sustained long-term effects in LTE; concomitantly, EEG revealed a significant decrease of δ and γ activity in primary and secondary auditory cortex as well as in frontal brain areas with enhanced α activity in auditory and prefrontal areas; additionally, tinnitus-related reduction of activity was reversed, and enhanced activity reoccurred in auditory and prefrontal areas |
| CR | Adamchic | 18 | Clinical trial | 16 min | 16 min | VAS-L, VAS-A, and EEG | Under stimulation-on conditions, both the CR group and noisy CR-like group had a reduction of VAS-L and VAS-A scores, together with a decrease of auditory δ power and an increase of auditory α and γ power; in contrast, the LFR group had less effects under stimulation-on conditions; the CR group had the longest significant reduction of δ and γ, and an increase of α power in the auditory cortex region; the noisy CR-like group had weaker electrophysiological after-effects, and the LFR group had hardly any electrophysiological after effects |
| NTT | Vieira | 70 | Clinical trial | 6 months | Transition: 2-month review appointment; follow up: 4-month review appointment; final: 6-month review appointment; long-term review: 6– 36 months after termination of the treatment | TRQ, tinnitus awareness and disturbance | There was a significant decrease in TRQ scores and tinnitus awareness and disturbance at the end of the treatment and at the long-term appointment, relative to the scores before treatment started; and the treatment outcome was stable beyond the conclusion of the NTT treatment program, since there was no significant change in any of the scores between the end of the treatment and long-term appointments, and patients meeting applicable standards had better outcomes |
| NTT | Li | 34 | RCT | 12 months | 12 months | THI and TFI | The treatment group reported significantly lower scores of THI (include tinnitus distress, severity, and functional impairment) than the control group (received unaltered music) throughout the treatment and follow-up period; among the treatment group, the total scores of THI and TFI were significantly lower at follow-up period than at baseline; despite sustained tinnitus severity improvement for the treatment group, the anxiety symptoms relapsed at the 12-month follow up |
| NTT | Newman and Sandrige[ | 56 | Comparative study | 6 months | 6 months | THI | THI scores indicated a significant improvement in tinnitus reduction for both treatment types, yet inter-group differences were not statistically significant; those patients with more severe THI scores at the beginning of therapy received greater benefit from treatment |
| NTT | Jang | 11 | Clinical trial | 6 months | 6 months | TRQ, awareness score, disturbance score, GBI | The participants achieved universal improvement in the scores of TRQ, GBI, and the awareness of tinnitus; 40% participants reported a reduction of the time they were disturbed by their tinnitus |
| NTT | Wazen | 38 | RCT | Treated for 2–4 h per day for 6 months | 24 months | TRQ, THI | The TRQ score was significantly reduced in 74% of patients at 12 months and in 84% of patients at 24 months; THI scores were significantly reduced in 77% of patients at 12 months and in 50% of patients at 24 months |
| NTT | McMahon | 12 | Clinical trial | 30 weeks | 30 weeks | MEG, TRQ | MEG recordings showed that the tinnitus participants had significantly larger and more anteriorly located source strengths when compared with the non-tinnitus participants; during the 30-week tinnitus treatment, the participants’ 500 Hz and 1000 Hz source strengths remained higher than the non-tinnitus participants; however, the source locations shifted toward the direction recorded from the non-tinnitus control group; further, the perceptual changes in tinnitus perception preceded neurophysiological changes by 5 weeks; in addition, the mild–severe subgroup had 500 Hz and 1000 Hz source locations located that were more anteriorly located compared with the mild–moderate group, which suggests that those with greater magnitudes of hearing loss showed greater cortical disruptions with tinnitus |
| Modulated sounds | Reavis | 20 | Clinical trial | 3 min | 3 min | Tinnitus Severity Index, THI, loudness growth experiment, tinnitus LM | After adjusting for stimulus frequency, all stimuli except for pure tones produced significantly greater amounts of suppression than white noise, with the amplitude-modulated tones producing the most (1.9 times more than white noise); after adjusting for stimulus type, only the highest-frequency stimuli (6–9 kHz) produced 1.5 times more suppression than white noise; besides, compared with good responders, poor responders matched their tinnitus to significantly lower sensation levels but had higher loudness rankings |
| Modulated sounds | Tyler | 56 | RCT | 6 min | 8 min | THQ, Tinnitus Pitch Match | In about one third (21/56) of subjects, there was no significant effect from any masker; in other subjects, 54.3% (19/35) showed a greater reduction for the S-tones, 20% (7/35) showed a greater reduction with the noise, and 25.7% (9/35) showed similar performance between the two stimuli; the S-tones showed a statistically significant benefit |
| Modulated sounds | Durai | 23 | Clinical trial | 2 weeks | 2 weeks | VAS-L, VAS-A, loudness level match | After short-term administration of 30 min, the scores of VAS-L and VAS-A were significantly lower for unpredictable sounds in comparison with baseline; and tinnitus was significantly less annoying, but to a lesser extent, after predictable sound administration than baseline; the loudness level matches are similar between conditions (baseline, predictable, unpredictable, and silent); the participants who had benefited from sound therapy reported a preference of unpredictable over predictable sounds |
| Modulated sounds | Schoisswohl | 29 | Clinical trial | 3 min × 7 | Assessed after each stimuli | VAS-L, RI | The results indicated a general efficacy of noise stimuli for the temporary suppression of tinnitus, but no significant differences between AM and unmodulated individualized bandpass-filtered stimuli; compared with the group with tonal tinnitus, the group with noise-like tinnitus revealed significantly better effects (showing a shorter duration of tinnitus and a lower VAS-L), especially directly after stimulation offset; further, no differences were found in scores of TQ and THI between the two subgroups |
| Modulated sounds | Neff | 29 | Comparative study | 3 min | Assessed every 30 s after the stimulation | RI, VAS-L | This study confirmed similar or slightly stronger tinnitus suppression or RI effects of AM compared with PTs and slightly better tolerability of the AM stimulus class by tinnitus sufferers |
| ADT | Herraiz | 67 | RCT | Treated for 20 min a day for 1 month | 1 month | RESP, THI, VAS | ADT patients improved significantly compared with WLG in RESP and THI scores; the NONSAME group (training frequencies one octave below the tinnitus pitch) had significantly decreased THI scores compared with the SAME group (patients trained frequencies similar to tinnitus pitch); RESP and VAS scores decreased more in the NONSAME group though differences were not significant; the result had not shown any differences when comparing the group training the deepest hearing-impaired frequency and the group who trained other frequencies |
| ADT | Hoare | 70 | RCT | 1 month | 1 month | THQ | An overall reduction in self-reported tinnitus handicap after training was maintained at a 1-month follow-up assessment, but there were no significant differences between groups (trained with different frequencies of stimulus/trained with different duration) |
| HA | Rocha and Mondelli[ | 30 | RCT | 6 months | 6 months | THI, VAS | The scores of the THI showed a reduction >20 points for 100% of the patients; additionally, in the results obtained by the VAS, both of the groups indicated an initial high improvement, with a lasting effect until the final assessment |
| HA | Henry | 55 | RCT | 5 months | 5 months | TFI, hearing-specific questionnaires and QuickSIN | All the groups had improvements in TFI, the hearing-specific questionnaires, and QuickSIN, but these improvements did not differ across device groups; but that the HA and HA+SG devices provided twice as much benefit as the EWHA device for listening to speech in noise; similarly, participants who wore the HA and HA+SG devices reported better overall objective and subjective auditory outcome than those who wore EWHA devices |
| HA | Henry | 30 | RCT | 3 months | 3 months | TFI | 87% of the participants with HA showed a significantly improvement in their TFI scores |
| HA | Santos | 49 | RCT | 3 months | 3 months | THI, numeric scale of tinnitus loudness | The results showed not statistically significant difference between the group of ‘HA+SG’ and ‘HA’; both of the groups showed a significant reduction in THI and MML; the results also show a positive correlation between the MML and the discomfort from tinnitus and the tinnitus loudness |
| HA | Sweetow and Sabes[ | 14 | Clinical trial | 6 months | 6 months | THI, TRQ | The participants were tested wearing HAs that contained several programs including amplification only, fractal tones only, and a combination of amplification, noise, and/or fractal tones; the majority reported improvements for at least one of the amplified conditions (with or without fractal tones or noise), relative to the unaided condition, and indicated that it was easier to relax while listening to fractal signals |
| CI | Buechner | 5 | Clinical trial | 12 months | 12 months | characterization of tinnitus, questionnaires regarding sound quality and tinnitus, | Participants 2 and 3 reported nearly complete suppression of the tinnitus while the implant was activated; however, the tinnitus returned after a couple of minutes to hours after switching off the device; although participants 2 and 5 reported a continuous improvement, for participants 3 and 4, the stress caused by the tinnitus increased again after the initial months; participant 1 did not notice any long-term effect of the CI on his tinnitus |
| CI | Zeng | 1 | Case report | 360 s | 720 s | VAS-L, EEG | A low-rate (20–100 Hz) and a low-level (softer than the tinnitus) electric stimulus delivered by CI totally abolished tinnitus; compared with the results obtained in the tinnitus-present state, the low-rate stimulus reduced cortical N100 potentials while increasing the spontaneous α power in the auditory cortex |
AC, active healthy control; ADT, auditory discrimination training; AM, amplitude modulated sound therapy; ASSR, auditory steady state response; BAI, Beck Anxiety Inventory; BBN, broadband noise; BSG, bedside sound generator; CGI-I7, Clinical Global Impression–Improvement Scale; CI, cochlear implant; CR, acoustic coordinated reset neuromodulation therapy; DMN, brain’s default-mode network; EEG, electroencephalogram; EWHA, extended-wear hearing aid; fMRI, functional magnetic resonance imaging; GBI, Glasgow Benefit Inventory; GM, gray matter; HA, hearing aid; HA+SG, hearing aid with a sound generator; HADS, Hospital Anxiety and Depression Scale; HNMT, Heidelberg neuro-music therapy; LFR, low-frequency-range stimulation; LM, tinnitus loudness matching; LTE, long-term extension period; MEG, magnetoencephalography; MML, minimum masking levels; NRS, Numeric Rating Scale; NS, noise stimulus; NTT, neuromonics tinnitus therapy; PCC, posterior cingulate cortex; PM, tinnitus pitch matching; PTs, pure tones; QuickSIN, Quick Speech in Noise test; PTC, passive tinnitus control; RCT, randomized controlled trial; RESP, patient’s answer to the question ‘Is your tinnitus better, the same, or worse since we started the treatment?’; RI, residual inhibition; SG, sound generator; TBF-12, Tinnitus-Beeinträchtigungs-Fragebogen; TED, tinnitus educational counseling; TEQ, Tinnitus Experience Questionnaire; TFI, Tinnitus Functional Index; TG, treatment group; THI, Tinnitus Handicap Inventory; THQ, Tinnitus Handicap Questionnaire; TIQ, Tinnitus Lifestyle Inventory Questionnaire; TM, tinnitus masking; TMNMT, tailor-made notched music training; TQ, Tinnitus Questionnaire total scores; TRT, tinnitus retraining therapy; TRQ, Tinnitus Reaction Questionnaire; VAS, Visual Analog Scale; VAS-A, Visual Analog Scale of tinnitus annoyance; VAS-L, Visual Analog Scale of tinnitus loudness; VNS, Visual Numeric Scale; WLC, wait-list control group; WLG, waiting list group.